Welcome to the MacDonald Women's Hospital Division of Gynecologic Oncology.
The Division’s guiding principal is not treating cancer, but treating women with cancer.
Patients are an integral part of the decision-making process and, in all cases, a top priority is given to pre-serving a women’s physical and emotional health.
Women who receive their care at Ireland Cancer Center benefit from having treatment coordi-nated by gynecologic oncologists specializing in the evaluation and management of women with suspected or confirmed gynecologic malignancies.
The Division’s four gynecologic oncologists collaborate with other team 
members at Ireland including chemotherapy nurse specialists, social workers, psychotherapists, and an office staff aware of the special concerns of women with gynecologic cancers. Management for each woman is individualized and may include surgery, chemtherapy, radiation therapy, care of treatment-related side effects and, when needed, coordination of hospice or palliative care.
Our Gynecologic Oncologists are members of the National Institutes of Health-sponsored Gyneco-logic Oncology Group (GOG), thus Ireland patients also have access to the latest development NIH-sponsored clinical research. These include trials for women with newly diagnosed or recurrent cancers, as well as studies aimed at preventing gynecologic cancers or improving the accuracy of early diagnosis. One trial is now enrolling women at high risk for ovarian cancer that is designed to detect the disease in its earliest stage or prevent it from developing at all. At any given time the Division has between 25 and 30 open clinical trials.
The Division’s members hold leader-ship roles in the GOG and participate in its cooperative clinical trials. In addition to its ongoing GOG studies, the Division also focuses on developing investigator-initiated trials.